|
Q4 2011
|
|
|
|
12/30/11
|
86.8% (46/53)
|
20.4%
|
|
12/22/11
|
86.5% (45/52)
|
2.5%
|
|
12/19/11
|
86.3% (44/51)
|
40%
|
|
12/6/11
|
86% (43/50)
|
14.4%
|
|
12/6/11
|
85.7% (42/49)
|
11%
|
|
12/6/11
|
85.4% (41/48)
|
-10.5%
|
|
12/5/11
|
87.2% (41/47)
|
9%
|
|
12/1/11
|
87% (40/46)
|
7.5%
|
|
11/23/11
|
86.7% (39/45)
|
-18.5%
|
|
11/23/11
|
88.6% (39/44)
|
-8.6%
|
|
11/21/11
|
90.7% (39/43)
|
2.6%
|
|
11/21/11
|
90.5% (38/42)
|
0.55%
|
|
11/14/11
|
90.2% (37/41)
|
5.4%
|
|
11/1/11
|
90% (36/40)
|
1.3%
|
|
10/31/11
|
89.7% (35/39)
|
2.7%
|
|
10/31/11
|
89.5% (34/38)
|
18%
|
|
10/27/11
|
89.2% (33/37)
|
2%
|
|
10/27/11
|
89% (32/36)
MF Global (MF)
Buy 10/26/11 AH | Sell 10/27/11 Pre-Mkt
|
20%
|
|
10/5/11
|
88.6% (31/35)
|
7.4%
|
|
Q3 2011
|
|
|
|
9/22/11
|
Teucrium Corn (CORN) PUT OPTIONS
Buy 8/23/11 | Sell 9/22/11
|
100%+
|
|
9/15/11
|
88.2% (30/34)
|
12%
|
|
9/12/11
|
88% (29/33)
|
2%
|
|
9/9/110
|
87.5% (28/32)
|
11%
|
|
9/7/11
|
87.1% (27/31)
|
10%
|
|
9/7/11
|
86.6% (26/30)
|
10.4%
|
|
9/7/11
|
86.2% (25/29)
|
7%
|
|
8/24/11
|
iPath DJ-UBS Coffee (JO)
Buy 8/11/11 | Sell 8/24/11
|
17%
|
|
8/5/11
|
85.7% (24/28)
|
5.5%
|
|
8/5/11
|
85.2% (23/27)
|
1.9%
|
|
7/27/11
|
PowerShares QQQ (QQQ) PUT OPTIONS
Buy 7/22/11 | Sell 7/27/11
|
100%
|
|
7/27/11
|
84.6% (22/26)
|
1.5%
|
|
7/27/11
|
84% (21/25)
|
-3.8%
|
|
7/20/11
|
87.5% (21/24)
|
-7.4%
|
|
7/19/11
|
91.3% (21/23)
|
1.7%
|
|
7/19/11
|
91% (20/22)
|
3.1%
|
|
7/14/11
|
90.5% (19/21)
|
16.7%
|
|
7/11/11
|
Stillwater Mining (SWC) PUT OPTIONS X2
Buy 7/7/11 | Sell 7/11/11
|
1,210% | 620%
|
|
7/1/11
|
Teucrium Corn (CORN) PUT OPTIONS X2
Buy 6/29/11 | Sell 7/1/11
|
188% | 141%
|
|
Q2 2011
|
|
|
|
6/28/11
|
90% (18/20)
|
14.4%
|
|
6/22/11
|
89.5% (17/19)
|
11.1%
|
|
5/9/11
|
89% (16/18)
|
2.3%
|
|
5/8/11
|
PowerShares Double Short Oil ETN (DTO)
Buy 5/1/11 | Sell 5/5/11
|
20%
|
|
5/5/11
|
iShares Silver Trust (SLV) PUT OPTIONS
Buy 4/11/11 | Sell 5/5/11
|
233%
|
|
4/29/11
|
88.2% (15/17)
|
107%
|
|
4/28/11
|
87.5% (14/16)
|
24.4%
|
|
4/27/11
|
86.7% (13/15)
|
17.8%
|
|
4/15/11
|
85.7% (12/14)
|
20%
|
|
4/14/11
|
84.6% (11/13)
|
7.1%
|
|
4/13/110
|
83.3% (10/12)
|
9.4%
|
|
4/10/11
|
Two OTC Cancer Drug Makers
Buy 1/14/11 | Sell 4/10/11
|
325% | 100%
|
|
4/9/11
|
Complete Genomics (GNOM)
Buy 11/21/10 | Sell 4/9/11
|
41%
|
|
Q1 2011
|
|
|
|
3/29/11
|
82% (9/11)
|
24.1%
|
|
3/24/11
|
80% (8/10)
|
13.4%
|
|
2/17/11
|
77.8% (7/9)
|
33.3%
|
|
2/3/11
|
75% (6/8)
|
18.3%
|
|
1/19/11
|
71.4% (5/7)
|
33.3%
|
|
1/5/11
|
86.7% (4/6)
|
3.4%
|
|
1/5/11
|
60% (3/5)
|
400%
|
|
1/3/11
|
50% (2/4)
|
-2.87%
|
|
1/3/11
|
66.7% (2/3)
|
-33.2%
|
|
1/3/11
|
100% (2/2)
|
17.8%
|
|
1/3/11
|
100% (1/1)
|
11.2%
|
